A Randomized Controlled Trial Comparing The Cosmetic Outcome Of Electrocautery Versus Scalpel For Thyroidectomy Incisions

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study looks at the difference in surgical scar outcomes between two different surgical incision methods during thyroid surgery: scalpel vs electrocautery. Patients who are already scheduled for thyroid surgery with Dr. Sam Wiseman, Endocrine Surgeon at St. Paul's Hospital, and that meet the eligibility criteria for this study will be invited to participate. After signing the informed consent form, participants will be randomized into either one of the two incision methods, but will not know which one they receive. There will be two follow-up time points: one at 6 and another at 12 months post-operative. At these time points the research team will send a letter to the participant asking them to rate the appearance of their surgical scar. They will also be asked to take a picture of their scar and send it back to the research team, so that the research team can make an assessment of their surgical scar. The study concludes when the 12 month follow-up is complete.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: t
View:

• Patients over 18 years old who have consented to conventional thyroid surgery with Dr. Sam Wiseman at St Paul's Hospital (Vancouver, BC) will be asked to participate.

Locations
Other Locations
Canada
St. Paul's Hospital
RECRUITING
Vancouver
Contact Information
Primary
Sam M Wiseman, MD
smwiseman@providencehealth.bc.ca
6048069108
Backup
Kaye Ong, BSc
kong@providencehealth.bc.ca
6046822344
Time Frame
Start Date: 2015-03
Estimated Completion Date: 2025-12
Participants
Target number of participants: 60
Treatments
Active_comparator: Scalpel
Use of a scalpel as a first incision during thyroid operation.
Experimental: Electrocautery
Use of an electrocautery as a first incision during thyroid operation.
Related Therapeutic Areas
Sponsors
Leads: Dr. Sam M. Wiseman

This content was sourced from clinicaltrials.gov